LTST
Lisata amends charter for Nov. 2026 15-for-1 reverse stock split
Lisata Therapeutics amended its charter to implement a 15-for-1 reverse stock split effective November 23, 2026, affecting shares, treasury stock, and options. Market relevance: This corporate action signals the company expects that its stock price will increase following the split, though the price…